28371
In a phase III clinical trial in patients with Cushing ' s disease , twice - daily pasireotide 600 or 900 mu g for 6 months led to normalization of urinary free cortisol ( UFC ) levels in up to a quarter of all patients ( primary endpoint ) and significantly reduced mean UFC levels .
 Chemical: pasireotide; Chemical: cortisol
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 Chemical: pasireotide; Chemical: cortisol